Unity Biotechnology, Inc. IPO Research Information

Unity Biotechnology, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Unity Biotechnology, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Unity Biotechnology, Inc.	UBX - NASDAQ	$16.00-$18.00	$17.00	$19.00	5 million	5/3/2018
Underwriter(s): Goldman Sachs & Co., Morgan Stanley, Citigroup
Co-Manager(s): Mizuho Securities
Industry: Health Care
Filing(s): Filed 2018-04-05 Terms Added 2018-04-23 Final Prospectus 2018-05-04

Unity Biotechnology, Inc. Quote & Chart - Click for current quote - UBX

About Unity Biotechnology, Inc. (adapted from Unity Biotechnology, Inc. prospectus):
They are looking to develop a broad portfolio of drug candidates to treat the diseases of aging, and they plan to initiate their first clinical study of their lead drug candidate in the first half of 2018.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "UBX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.